Pliant Therapeutics, Inc.
PLRX
$1.33
$0.021.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.69M | 10.33M | 13.39M | 15.50M | 14.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.48M | 28.37M | 45.59M | 58.94M | 53.32M |
| Operating Income | -13.48M | -28.37M | -45.59M | -58.94M | -53.32M |
| Income Before Tax | -23.58M | -26.30M | -43.30M | -56.17M | -49.73M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.58M | -26.30M | -43.30M | -56.17M | -49.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.58M | -26.30M | -43.30M | -56.17M | -49.73M |
| EBIT | -13.48M | -28.37M | -45.59M | -58.94M | -53.32M |
| EBITDA | -13.11M | -27.93M | -45.15M | -58.49M | -52.86M |
| EPS Basic | -0.38 | -0.43 | -0.71 | -0.92 | -0.82 |
| Normalized Basic EPS | -0.12 | -0.27 | -0.44 | -0.57 | -0.51 |
| EPS Diluted | -0.38 | -0.43 | -0.71 | -0.92 | -0.82 |
| Normalized Diluted EPS | -0.12 | -0.27 | -0.44 | -0.57 | -0.51 |
| Average Basic Shares Outstanding | 61.45M | 61.41M | 61.39M | 61.22M | 60.85M |
| Average Diluted Shares Outstanding | 61.45M | 61.41M | 61.39M | 61.22M | 60.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |